Instituto de Fisiología Experimental (IFISE), Facultad de Ciencias Bioquímicas y Farmacéuticas (CONICET-U.N.R.), Suipacha 570, S2002LRL, Rosario, Argentina.
Arch Toxicol. 2018 Feb;92(2):729-744. doi: 10.1007/s00204-017-2098-3. Epub 2017 Oct 31.
Estradiol-17β-D-glucuronide (E17G), through the activation of different signaling proteins, induces acute endocytic internalization of canalicular transporters in rat, including multidrug resistance-associated protein 2 (Abcc2) and bile salt export pump (Abcb11), generating cholestasis. Insulin-like growth factor 1 receptor (IGF-1R) is a membrane-bound tyrosine kinase receptor that can potentially interact with proteins activated by E17G. The aim of this study was to analyze the potential role of IGF-1R in the effects of E17G in isolated perfused rat liver (IPRL) and isolated rat hepatocyte couplets. In vitro, IGF-1R inhibition by tyrphostin AG1024 (TYR, 100 nM), or its knock-down with siRNA, strongly prevented E17G-induced impairment of Abcc2 and Abcb11 function and localization. The protection by TYR was not additive to that produced by wortmannin (PI3K inhibitor, 100 nM), and both protections share the same dependency on microtubule integrity, suggesting that IGF-1R shared the signaling pathway of PI3K/Akt. Further analysis of the activation of Akt and IGF-1R induced by E17G indicated a sequence of activation GPR30-IGF-1R-PI3K/Akt. In IPRL, an intraportal injection of E17G triggered endocytosis of Abcc2 and Abcb11, and this was accompanied by a sustained decrease in the bile flow and the biliary excretion of Abcc2 and Abcb11 substrates. TYR did not prevent the initial decay, but it greatly accelerated the recovery to normality of these parameters and the reinsertion of transporters into the canalicular membrane. In conclusion, the activation of IGF-1R is a key factor in the alteration of canalicular transporter function and localization induced by E17G, and its activation follows that of GPR30 and precedes that of PI3K/Akt.
雌二醇-17β-D-葡糖苷酸(E17G)通过激活不同的信号蛋白,诱导大鼠胆小管转运蛋白的急性内吞内化,包括多药耐药相关蛋白 2(Abcc2)和胆汁盐输出泵(Abcb11),导致胆汁淤积。胰岛素样生长因子 1 受体(IGF-1R)是一种膜结合的酪氨酸激酶受体,它可以与 E17G 激活的蛋白质潜在相互作用。本研究旨在分析 IGF-1R 在 E17G 对离体大鼠肝灌注(IPRL)和离体大鼠肝细胞偶联的潜在作用。在体外,IGF-1R 抑制剂 tyrphostin AG1024(TYR,100 nM)或 siRNA 敲低强烈阻止了 E17G 诱导的 Abcc2 和 Abcb11 功能和定位的损害。TYR 的保护作用与wortmannin(PI3K 抑制剂,100 nM)的保护作用没有叠加,并且这两种保护作用都依赖于微管的完整性,表明 IGF-1R 与 PI3K/Akt 信号通路共享。对 E17G 诱导的 Akt 和 IGF-1R 激活的进一步分析表明,GPR30-IGF-1R-PI3K/Akt 是激活的顺序。在 IPRL 中,门静脉内注射 E17G 触发了 Abcc2 和 Abcb11 的内吞作用,同时伴随着胆汁流量和 Abcc2 和 Abcb11 底物的胆汁排泄持续减少。TYR 并没有阻止初始的衰减,但它大大加速了这些参数恢复正常和转运蛋白重新插入胆小管膜的过程。总之,IGF-1R 的激活是 E17G 诱导胆小管转运蛋白功能和定位改变的关键因素,其激活先于 GPR30 并紧随 PI3K/Akt 之后。